Skip to main content Back to Top
Advertisement

Midyear 2023 Highlights - Research Best Practices for Student

February 8, 2024

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Amy Barton Alston chats with Drs. Kamakshi Rao and Katie Cho after their presentation titled The Way to Begin is to Begin: Writing Yor First Research Proposal at the Midyear Clinical Meeting.  In this episode, they identify tips and trips for students who are interested in pursuing research projects.

SPEAKERS

Kamakshi RaoKamakshi Rao, PharmD, BCOP, FASHP oversees Adult Ambulatory and Acute Clinical Services as well as the hospital’s academic enterprises, including resident and student training programs and leads the department’s growing efforts around diversity, equity, and inclusion. She spent 20 years in direct patient care, working with patients undergoing bone marrow transplants at the North Carolina Cancer Hospital and brings her passion for patient care and education to build programs that support the training and leadership of highly skilled, passionate, and wholehearted clinical pharmacists.

Katherine ChoKatie Cho, PharmD, BCACP is a Clinical Assistant Professor of Ambulatory Care at Temple University School of Pharmacy and a Clinical Pharmacist at Temple Internal Medicine, working with patients with diabetes, hypertension, and dyslipidemias. In addition to clinical responsibilities, Dr. Cho teaches within the didactic curriculum and in research electives to encourage student involvement in clinically meaningful pharmacy research. She completed post-graduate residency and fellowship and brings her commitment to education and clinical expertise to support student and resident researchers.

Amy Barton AlstonAmy Barton Alston, PharmD, MS, CMPP, FASN, FCCP, FNKF has had a 20+ year career as an academic researcher focused on translational investigations of intravenous iron-carbohydrate nanomedicines in the chronic kidney disease population. She was previously funded by the FDA to advance bioequivalence evaluation for intravenous iron-carbohydrate nanomedicines using in vitro and pre-clinical models. Dr. Alston also maintained a clinical practice providing care to patients across the chronic kidney disease continuum with a focus on the in-center hemodialysis population.


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.